Clinical Characteristics of 144 patients (pts) Included in a Multidisciplinary Group, with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) G2 (WHO 2010). Grupo Argentum.
Introduction: Neuroendocrine tumors (NETs) G2 of the digestive tract are a heterogeneous group of tumors. Several treatment options including chemotherapy and target therapy are used, but there is a lack of prospective trials assessing the role of predictive factors in this population.
Aim(s): To analyze prognostic factors and clinical characteristics in a population of patients with GEP-NETs G2. To determine the role of Ki-67 in the stratification of the G2 population.
Materials and methods: Study population was obtained from our database (Argentum Group). Survival was estimated using the Kaplan-Meier method and compared between Ki-67 quartiles using the log-rank test. Value of Ki-67 to discriminate mortality was assesed with an ROC curve analysis.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: OConnor J
To read the full abstract, please log into your ENETS Member account.